Identification of a biomarker in cerebrospinal fluid for neuronopathic forms of Gaucher disease

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Zigdon, Hila ^a   Savidor, Alon ^a   Levin, Yishai ^a   Meshcheriakova, Anna ^a   Schiffmann, Raphael ^b   Futerman, Anthony H ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLYCOPROTEIN; GLYCOPROTEIN NON METASTATIC B; UNCLASSIFIED DRUG; GPNMB PROTEIN, HUMAN; MEMBRANE PROTEIN;

ADULT; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; GAUCHER DISEASE; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MOUSE; NONHUMAN; PRESCHOOL CHILD; PROTEIN DETERMINATION; PROTEOMICS; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY; ADOLESCENT; ANIMAL; BRAIN; C57BL MOUSE; CASE CONTROL STUDY; CEREBROSPINAL FLUID; FEMALE; MALE; METABOLISM; MOLECULAR GENETICS; PATHOLOGY;

ADOLESCENT; AMINO ACID SEQUENCE; ANIMALS; BIOMARKERS; BRAIN; CASE-CONTROL STUDIES; CHILD; FEMALE; GAUCHER DISEASE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA;

EID: 84925268954     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0120194     Document Type: Article

References (32)

1. Futerman AH, Zimran A (2006) Gaucher disease. Taylor and Francis Group, Boca Raton, FL: CRC Press. 1 pp.
2. Grabowski GA, Beutler E (2006) The online metabolic and molecular bases of inherited iseases. Chapter 146: Gaucher disease. Valle D, Beaudet A, Vogelstein B, Kinzler K, Antonarakis S, editors New York: McGraw-Hill.
3. Vitner EB, Futerman AH (2013) Neuronal forms of Gaucher disease. Handb Exp Pharmacol 216: 405-419. doi: 10.1007/978-3-7091-1511-4-20 PMID: 23563668
4. Vitner EB, Salomon R, Farfel-Becker T, Meshcheriakova A, Ali M, Klein AD, et al. (2014) RIPK3 as a potential therapeutic target for Gaucher's disease. Nat Med 20: 204-208. doi: 10.1038/nm.3449 PMID: 24441827
5. Mignot C, Geolt A, De Villemeur T (2012) Gaucher disease. Handb Clin Neurol 113: 1709-1715.
6. Sidransky E, Nalls MA, Aasly JO, Aharon-Peretz J, Annesi G, Barbosa ER, et al. (2009) Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med 361: 1651-1661. doi: 10.1056/NEJMoa0901281 PMID: 19846850
7. Hruska KS, Goker-Alpan O, Sidransky E (2006) Gaucher disease and the synucleinopathies. J Biomed Biotechnol 2006: 78549. PMID: 17047314
8. Schiffmann R, FitzGibbon EJ, Harris C, DeVile C, Davies EH, Abel L, et al. (2008) Randomized, controlled trial of miglustat in Gaucher's disease type 3. Annals of Neurology 64: 514-522. doi: 10.1002/ ana.21491 PMID: 19067373
9. Benko W, Ries M, Wiggs EA, Brady RO, Schiffmann R, Fitzgibbon EJ (2011) The saccadic and neurological deficits in type 3 Gaucher disease. PLoS ONE 6: e22410. doi: 10.1371/journal.pone.0022410 PMID: 21799847
10. Pelled D, Trajkovic-Bodennec S, Lloyd-Evans E, Sidransky E, Schiffmann R, Futerman AH (2005) Enhanced calcium release in the acute neuronopathic form of Gaucher disease. Neurobiol Dis 18: 83-88.PMID: 15649698
11. Enquist IB, Bianco Lo C, Ooka A, Nilsson E, Månsson J-E, Ehinger M, et al. (2007) Murine models of acute neuronopathic Gaucher disease. Proc Natl Acad Sci USA 104: 17483-17488. PMID: 17954912
12. Farfel-Becker T, Vitner EB, Pressey SNR, Eilam R, Cooper JD, Futerman AH (2011) Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic Gaucher disease. Hum Mol Genet 20: 1375-1386. doi: 10.1093/hmg/ddr019 PMID: 21252206
13. Premkumar L, Sawkar AR, Boldin-Adamsky S, Toker L, Silman I, Kelly JW, et al. (2005) X-ray structure of human acid-beta-glucosidase covalently bound to conduritol-B-epoxide. Implications for Gaucher disease. J Biol Chem 280: 23815-23819. PMID: 15817452
14. Kelstrup CD, Young C, Lavallee R, Nielsen ML, Olsen JV (2012) Optimized fast and sensitive acquisition methods for shotgun proteomics on a quadrupole orbitrap mass Spectrometer. J Proteome Res 11: 3487-3497. doi: 10.1021/pr3000249 PMID: 22537090
15. Vizcaíno JA, Deutsch EW, Wang R, Csordas A, Reisinger F, Ríos D, et al. (2014) ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat Biotechnol 32: 223-226. doi: 10.1038/nbt.2839 PMID: 24727771
16. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297: 353-356. PMID: 12130773
17. Bloom GS (2014) Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol 71: 505-508. doi: 10.1001/jamaneurol.2013.5847 PMID: 24493463
18. Burrow TA, Sun Y, Prada CE, Bailey L, Zhang W, Brewer A, et al. (2014) CNS, lung, and lymph node involvement in Gaucher disease type 3 after 11years of therapy: Clinical, histopathologic, and biochemical findings. Mol Genet Metab.
19. Hollak CE, van Weely S, van Oers MH, Aerts JM (1994) Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest 93: 1288-1292. PMID: 8132768
20. Furochi H, Tamura S, Mameoka M, Yamada C, Ogawa T, Hirasaka K, et al. (2007) Osteoactivin fragments produced by ectodomain shedding induce MMP-3 expression via ERK pathway in mouse NIH-3T3 fibroblasts. FEBS Lett 581: 5743-5750. PMID: 18036345
21. Ripoll VM, Irvine KM, Ravasi T, Sweet MJ, Hume DA (2007) Gpnmb is induced in macrophages by IFN-gamma and lipopolysaccharide and acts as a feedback regulator of proinflammatory responses. J Immunol 178: 6557-6566. PMID: 17475886
22. Tanaka H, Shimazawa M, Kimura M, Takata M, Tsuruma K, Yamada M, et al. (2012) The potential of GPNMB as novel neuroprotective factor in amyotrophic lateral sclerosis. Sci Rep 2: 573. doi: 10.1038/ srep00573 PMID: 22891158
23. Mistry PK, Liu J, Yang M, Nottoli T, McGrath J, Jain D, et al. (2010) Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage. Proc Natl Acad Sci USA 107: 19473-19478. doi: 10.1073/pnas.1003308107 PMID: 20962279
24. Moran MT, Schofield JP, Hayman AR, Shi GP, Young E, Cox TM (2000) Pathologic gene expression in Gaucher disease: up-regulation of cysteine proteinases including osteoclastic cathepsin K. Blood 96: 1969-1978. PMID: 10961902
25. Schiffmann R, Heyes MP, Aerts JM, Dambrosia JM, Patterson MC, DeGraba T, et al. (1997) Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease. Annals of Neurology 42: 613-621. PMID: 9382473
26. Cluzeau CVM, Watkins-Chow DE, Fu R, Borate B, Yanjanin N, Dail MK, et al. (2012) Microarray expression analysis and identification of serum biomarkers for Niemann-Pick disease, type C1. Hum Mol Genet 21: 3632-3646. doi: 10.1093/hmg/dds193 PMID: 22619379
27. Parente MK, Rozen R, Cearley CN, Wolfe JH (2012) Dysregulation of gene expression in a lysosomal storage disease varies between brain regions implicating unexpected mechanisms of neuropathology. PLoS ONE 7: e32419. doi: 10.1371/journal.pone.0032419 PMID: 22403656
28. Myerowitz R, Mizukami H, Richardson KL, Finn LS, Tifft CJ, Proia RL (2004) Global gene expression in a type 2 Gaucher disease brain. Mol Genet Metab 83: 288-296. PMID: 15589115
29. Cimaz R, Coppa GV, Koné-Paut I, Link B, Pastores GM, Elorduy MR, et al. (2009) Joint contractures in the absence of inflammation may indicate mucopolysaccharidosis. Pediatr Rheumatol Online J 7: 18. doi: 10.1186/1546-0096-7-18 PMID: 19852785
30. Tessitore A, Pirozzi M, Auricchio A (2009) Abnormal autophagy, ubiquitination, inflammation and apoptosis are dependent upon lysosomal storage and are useful biomarkers of mucopolysaccharidosis VI. Pathogenetics 2: 4. doi: 10.1186/1755-8417-2-4 PMID: 19531206
31. McGeer PL, McGeer EG (2002) Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 26: 459-470. PMID: 12362410
32. Myerowitz R, Lawson D, Mizukami H, Mi Y, Tifft CJ, Proia RL (2002) Molecular pathophysiology in Tay-Sachs and Sandhoff diseases as revealed by gene expression profiling. Hum Mol Genet 11: 1343-1350. PMID: 12019216